John Richard Pinion - Oct 14, 2021 Form 4 Insider Report for Ultragenyx Pharmaceutical Inc. (RARE)

Role
EVP of Translational Sciences and Chief Quality Officer
Signature
/s/ Karah Parschauer, attorney-in-fact
Stock symbol
RARE
Transactions as of
Oct 14, 2021
Transactions value $
-$29,048
Form type
4
Date filed
10/18/2021, 06:41 PM
Previous filing
May 10, 2021
Next filing
Mar 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RARE Common Stock Sale -$29K -358 -0.71% $81.14 49.8K Oct 14, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").
F2 Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Remarks:

EVP of Translational Sciences and Chief Quality Officer